Sequencer Products: SEQ ALL
Technologies
Applications
Online Resources
Data Bulletins
Service & Support
Introduction
Newsroom
Doing Business With Us
Creative Club
Changchun, China, 23 September 2021 - The 13th China-Northeast Asia Expo is taking place from September 23rd to 27th in Changchun, Northeast China's Jilin province. MGI showcases its innovative platforms, including MGI Container Lab and MGISTP-7000 High-throughput Automated Sample Transfer Processing System, which have significantly contributed to China's participation in international cooperation in fighting against COVID-19.
MGISTP-7000 integrates tube uncapping, tube recapping, barcode identification, automated liquid transfer and negative pressure protection. With just a single-click, it can load original samples with caps, and transfer up to 192 samples from airtight sample tubes or plain tubes to 96-well microplates in 40 minutes, with zero human contact during the process. MGISTP-7000 minimizes the labor required, and significantly shorten the time required to transfer and prepare the samples, thus improving the operational efficiency and testing throughput. It has been contributing to fighting through multiple "battles" against COVID-19 internationally.
MGI automation systems are playing an instrumental role in the national pandemic control and prevention by enabling fast-turn-around COVID-19 testing. MGI's innovative platforms have supported 24 cities in China to date. In March this year, MGI Container Lab supported the large-scale COVID-19 testing in Stockholm, Sweden to safeguard the World Figure Skating Championships.
"Featuring high mobility, flexibility, and quick results, MGI's mobile platforms can be flexibly installed in outdoor places to meet the urgent testing needs in response to sudden outbreaks." Said Lin Siyuan, Director of Mobile Lab at MGI.
China is actively involved in the international fight against. COVID-19, contributing its share to upholding global public health security. MGI will continue to provide more solutions with Chinese hard core technology and professional frontline experience for the global epidemic prevention and control. As of December 2020, MGI has provided instrumental support for the diagnosis of suspected COVID-19 cases and subsequent research and analysis of the virus in more than 50 countries, contributing to the global combat against COVID-19.
